用于矫正无晶状体眼的眼内金属晶状体

[Intraocular metallic crystalline lens for correction of aphakia].

作者信息

Aderikhin I V, Golubchik V L, Gorban' A I, Kolbin M N

出版信息

Vestn Oftalmol. 1995 Jul-Sep;111(3):4-7.

Abstract

Technological characteristics of a new in principle intraocular lens (IOL) consisting of a leukosaphire lens and elastic tantalum haptics are presented. The advantages of metallic crystal IOLs are validated: complete chemical and biological inertness, longevity, high transparency, and easy implantation in the capsular sac. Surgical recommendations are offered and highly positive results of clinical trials analyzed (more than 600 implantations followed up for up to 4 years). Metallic crystal IOLs for intracapsular correction of aphakia developed at the S. I. Vavilov All-Russian Research Center and St. Petersburg Division of the Moscow Research and Technological Complex "Ocular Microsurgery" and manufactured by the IOL Joint Stock Company are recommended for wide clinical use.

摘要

介绍了一种原理全新的人工晶状体（IOL）的技术特性，该人工晶状体由白蓝宝石晶状体和弹性钽袢组成。验证了金属晶体人工晶状体的优点：完全的化学和生物惰性、使用寿命长、高透明度以及易于植入囊袋内。提供了手术建议并分析了临床试验的高度积极结果（600多次植入，随访长达4年）。推荐由全俄S. I. 瓦维洛夫研究中心、莫斯科研究与技术综合体“眼科显微手术”圣彼得堡分部研发并由人工晶状体股份公司制造的用于无晶状体囊内矫正的金属晶体人工晶状体广泛应用于临床。